HeartSciences Inc. (HSCS): Nasdaq/NYSE listing notice — Heart Test Laboratories (HSCS) gets Nasdaq bid price deficiency notice; has 180 days to cure

HeartSciences Inc.

Nasdaq notified HSCS on Aug 2, 2023 that common stock bid price was below $1.00 for 30 consecutive business days.
No immediate impact on listing; company has 180 calendar days to regain compliance (close at $1.00+ for 10 straight days).
If not cured, HSCS may qualify for an extra 180-day period by meeting other initial listing standards and intending a reverse split.
Failure to cure could lead to delisting; company is evaluating options to regain compliance.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

HeartSciences Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

August 2, 2023, Heart Test Laboratories, Inc. (the “Company”) received a notification letter from the Listing Qualifications Department of The Nasdaq Stock Market, LLC (“Nasdaq”) notifying the Company that, based on the closing bid price for the previous 30 consecutive business days, the listing of the Company’s shares of common stock was not in compliance with Nasdaq Listing Rule 5550(a)(2) to maintain a minimum bid price of $1.00 per share (the “Bid Price Rule”). The letter from Nasdaq has no immediate effect on the listing of the Company’s common stock on The Nasdaq Capital Market. In accor

View on SEC.gov

Browse all listing & compliance notices →

HeartSciences Inc. filing history →

Source: SEC EDGAR

accession 0000950170-23-038648

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.